✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Insulet Corp

Common Name
Insulet
Country
United States
Sector
Healthcare
Industry
Medical Devices
Employees
5,400
Ticker
PODD
Exchange
NASDAQ/NGS
Description
Insulet Corporation is a medical device company that develops, manufactures, and sells innovative insulin delivery systems, primarily through its Omnipod product platform, for people with insulin-depe...

Insulet's GHG Emissions Data Preview

In 2024, Insulet completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Insulet has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021-2019
Total Scope 1
1,383a
1,316a
1,455a
Total Scope 2
Market-Based
11,467a
3,977a
4,574a
Location-Based
11,057a
3,574a
3,556a
Total Scope 3
N/AN/AN/A
Total Scope 1 Revenue Intensity (tCO2e/$M)
0.6676a
0.7754a
1.1147a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=PODD&reporting_period=2024"

Verified Sources Behind Insulet’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Insulet's ESG Data Spreadsheet 2024
b. Insulet's ESG Data Spreadsheet 2021

Insights into Insulet's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Insulet amounted to 12,440 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Insulet increased by 154.4%, suggesting that the company faced challenges in reducing its emissions from its core operations.a

Insulet's Scope 1 Emissions Over Time

2020202120222023202404509001.35 k1.8 ktCO2e-17%+3%-10%+5%
  • Total Scope 1
  • Year-over-Year Change

What are Insulet's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Insulet were 1,383 metric tons of CO₂ equivalent (tCO₂e).a

Has Insulet reduced its Scope 1 emissions over time?

Since 2020, Insulet's Scope 1 emissions have decreased by 19.08%, reflecting a declining long-term trend in Scope 1 emissions over time.ab

Compared to the previous year (2023), Insulet's Scope 1 emissions increased by 5.09%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a

What are Insulet's Scope 2 emissions?

In 2024, Insulet reported Scope 2 greenhouse gas (GHG) emissions of 11,467 tCO₂e using the market-based method and 11,057 tCO₂e using the location-based method.a

Has Insulet reduced its Scope 2 emissions over time?

Since 2020, Insulet's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have increased by 386.45%, reflecting a rising long-term trend in Scope 2 emissions over time.ab

Compared to the previous year (2023), Insulet's Scope 2 emissions (Location-Based) rose by 209.37% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energya

What methodology does Insulet use for Scope 2 reporting?

In 2024, Insulet reported its Scope 2 emissions using the market-based method and using the location-based method.a

Insulet's Scope 2 Emissions Over Time

2020202120222023202403 k6 k9 k12 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Insulet’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Insulet reported Scope 1 greenhouse gas (GHG) emissions of 1,383 tCO₂e and total revenues of USD 2,072 millions. This translates into an emissions intensity of 0.67 tCO₂e per millions USD.a

Insulet's Scope 1 Emissions Intensity Compared to Peers

205005,000100,0002,000,000Scope 1 Emissions (tCO2e)1005005,00020,000100,000Revenues (Millions of USD)GN Store NordYear: 2025Scope 1: 2,912 tCO2eRevenue: $M 2,642Scope 1 Intensity: 1.10 tCO2e/$MCochlearYear: 2025Scope 1: 951 tCO2eRevenue: $M 1,542Scope 1 Intensity: 0.62 tCO2e/$MSysmexYear: 2024Scope 1: 13,449 tCO2eRevenue: $M 3,047Scope 1 Intensity: 4.41 tCO2e/$MGetinge publYear: 2025Scope 1: 11,650 tCO2eRevenue: $M 3,802Scope 1 Intensity: 3.06 tCO2e/$MDemantYear: 2025Scope 1: 15,893 tCO2eRevenue: $M 3,616Scope 1 Intensity: 4.40 tCO2e/$MUnited ImagingYear: 2024Scope 1: 3,123 tCO2eRevenue: $M 1,411Scope 1 Intensity: 2.21 tCO2e/$MVarex ImagingYear: 2023Scope 1: 4,856 tCO2eRevenue: $M 893Scope 1 Intensity: 5.44 tCO2e/$MAvanos MedicalYear: 2023Scope 1: 1,787 tCO2eRevenue: $M 673Scope 1 Intensity: 2.65 tCO2e/$MInspire Medical SystemsYear: 2023Scope 1: 51 tCO2eRevenue: $M 625Scope 1 Intensity: 0.08 tCO2e/$MZimmer Biomet HoldingsYear: 2024Scope 1: 10,191 tCO2eRevenue: $M 7,679Scope 1 Intensity: 1.33 tCO2e/$MDexcomYear: 2024Scope 1: 8,328 tCO2eRevenue: $M 4,033Scope 1 Intensity: 2.07 tCO2e/$MGE Healthcare TechnologiesYear: 2024Scope 1: 104,974 tCO2eRevenue: $M 19,672Scope 1 Intensity: 5.34 tCO2e/$MEdwards LifesciencesYear: 2024Scope 1: 15,682 tCO2eRevenue: $M 5,439Scope 1 Intensity: 2.88 tCO2e/$MBoston ScientificYear: 2024Scope 1: 87,567 tCO2eRevenue: $M 16,747Scope 1 Intensity: 5.23 tCO2e/$MStrykerYear: 2023Scope 1: 54,854 tCO2eRevenue: $M 20,498Scope 1 Intensity: 2.68 tCO2e/$MAbbott LaboratoriesYear: 2025Scope 1: 499,000 tCO2eRevenue: $M 44,328Scope 1 Intensity: 11.26 tCO2e/$MGlaukosYear: 2024Scope 1: 523 tCO2eRevenue: $M 383Scope 1 Intensity: 1.36 tCO2e/$MIntegra Lifesciences HoldingsYear: 2024Scope 1: 14,555 tCO2eRevenue: $M 1,611Scope 1 Intensity: 9.04 tCO2e/$MQuidelOrthoYear: 2023Scope 1: 22,544 tCO2eRevenue: $M 2,998Scope 1 Intensity: 7.52 tCO2e/$MEnovisYear: 2024Scope 1: 2,321 tCO2eRevenue: $M 2,108Scope 1 Intensity: 1.10 tCO2e/$MInteger HoldingsYear: 2023Scope 1: 7,066 tCO2eRevenue: $M 1,597Scope 1 Intensity: 4.43 tCO2e/$MBrukerYear: 2022Scope 1: 3,621 tCO2eRevenue: $M 2,531Scope 1 Intensity: 1.43 tCO2e/$MBio Rad LaboratoriesYear: 2023Scope 1: 10,563 tCO2eRevenue: $M 2,671Scope 1 Intensity: 3.95 tCO2e/$MInsuletYear: 2024Scope 1: 1,383 tCO2eRevenue: $M 2,072Scope 1 Intensity: 0.67 tCO2e/$M

How does Insulet's GHG emissions intensity compare to its peers?

In 2024, Insulet reported a Scope 1 emissions intensity of 0.67 tCO₂e per millions USD. Compared to the peer group median of 2.88, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does Insulet rank on GHG emissions intensity within its industry?

In 2024, Insulet ranked 3 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

This places Insulet among the top performers, with one of the lowest emissions intensities relative to peers.a

Want Full Access to Insulet's GHG Emissions Dataset?
Start 30-Day Free Trial